arrow_back Civic Audit
Share share

Securing US Medical Supplies for Emergencies

This act aims to strengthen domestic production of essential medicines and medical materials to ensure their availability during crises. This means greater health security for citizens, as the government will be able to respond more quickly to supply shortages, especially during pandemics or other threats.
Key points
Strengthening domestic production of medicines and medical equipment to reduce reliance on foreign suppliers.
The US President must develop a strategy to ensure the continuity of essential medical material supplies.
Possibility of investing in companies producing critical components and technologies for supply chain security.
article Official text account_balance Process page notifications_active Track this Bill
gavel
Status:
Expired
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
Print number: 117_HR_3146
Sponsor: Rep. Hill, J. French [R-AR-2]
Process start date: 2021-05-12
System Note: Lustra is free, publicly auditable civic infrastructure, with full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source, always verify them if you can.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

SAVE Act of 2021

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_HR_3146.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2021-05-12.

What are the main provisions?

Key points include:

  • Strengthening domestic production of medicines and medical equipment to reduce reliance on foreign suppliers.
  • The US President must develop a strategy to ensure the continuity of essential medical material supplies.
  • Possibility of investing in companies producing critical components and technologies for supply chain security.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Hill, J. French [R-AR-2].

What is the latest detailed status?

The latest detailed status is: On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H2454-2455)

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-27.

What is the impact of this bill?

We don't know, that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge.

CATEGORIES

Health Security Economy